Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FFHS4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,256
Award facts
- Contract value 100% obligated
- $28,256.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,256.30 delivery order to AmerisourceBergen Drug Corp for STELARA 45 mg/0.5 ml syringes on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. STELARA (ustekinumab) is a biologic immunosuppressant used to treat inflammatory conditions including psoriasis, psoriatic arthritis, and Crohn's disease, representing a specialized pharmaceutical procurement to support federal healthcare requirements.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems, AmerisourceBergen demonstrates extensive capability in fulfilling complex medical supply needs across therapeutic domains. The parent IDC enables the company to supply specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers worldwide.
Quick answers
Who was awarded contract SPE2DB25FFHS4?
SPE2DB25FFHS4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FFHS4 worth?
The government has obligated $28,256 on SPE2DB25FFHS4.
Is contract SPE2DB25FFHS4 an order under another contract?
Yes. SPE2DB25FFHS4 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFHS4 competed?
The extent of competition for SPE2DB25FFHS4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award